ArticleFrontiers in immunology2023

SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experience.

Federica Pulvirenti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.